These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1193 related items for PubMed ID: 26821965

  • 1. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 2. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
    Tarr T, Papp G, Nagy N, Cserép E, Zeher M.
    Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain RJEM, Zirkzee E, Fritsch-Stork R, Bultink IEM, Kamphuis S.
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [Abstract] [Full Text] [Related]

  • 4. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA, Abaza NM, Hammam N, Mohamed AAA, El-Gazzar II, Eissa AH.
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [Abstract] [Full Text] [Related]

  • 5. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
    Maloney KC, Ferguson TS, Stewart HD, Myers AA, De Ceulaer K.
    Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
    [Abstract] [Full Text] [Related]

  • 6. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
    [Abstract] [Full Text] [Related]

  • 7. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
    Taraborelli M, Cavazzana I, Martinazzi N, Lazzaroni MG, Fredi M, Andreoli L, Franceschini F, Tincani A.
    Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus.
    Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Ugalde J, Aguirre C.
    Lupus; 2004 Oct; 13(12):900-5. PubMed ID: 15645743
    [Abstract] [Full Text] [Related]

  • 9. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [Abstract] [Full Text] [Related]

  • 10. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
    Aljohani R, Gladman DD, Su J, Urowitz MB.
    Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
    [Abstract] [Full Text] [Related]

  • 11. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
    Taraborelli M, Leuenberger L, Lazzaroni MG, Martinazzi N, Zhang W, Franceschini F, Salmon J, Tincani A, Erkan D.
    Lupus; 2016 Oct; 25(12):1365-8. PubMed ID: 26945023
    [Abstract] [Full Text] [Related]

  • 12. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    Ceccarelli F, Pirone C, Mina C, Mascolo A, Perricone C, Massaro L, Spinelli FR, Alessandri C, Valesini G, Conti F.
    PLoS One; 2019 Oct; 14(11):e0224437. PubMed ID: 31682630
    [Abstract] [Full Text] [Related]

  • 13. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J, Handwerger B.
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [Abstract] [Full Text] [Related]

  • 14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 15. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
    [Abstract] [Full Text] [Related]

  • 16. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 17. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
    Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS.
    Lupus; 2003 Nov; 12(8):600-6. PubMed ID: 12945718
    [Abstract] [Full Text] [Related]

  • 18. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
    Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.
    Arthritis Rheumatol; 2020 Apr; 72(4):658-666. PubMed ID: 31631584
    [Abstract] [Full Text] [Related]

  • 19. The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts.
    Frodlund M, Reid S, Wetterö J, Dahlström Ö, Sjöwall C, Leonard D.
    Lupus; 2019 Sep; 28(10):1261-1272. PubMed ID: 31296137
    [Abstract] [Full Text] [Related]

  • 20. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.